IN8bio Inc - fluxo de caixa trimestral (NASDAQ:INAB)

Financials

Total assets 20.94 M19.87 M19.37 M16.77 M32.28 M Total liabilities 6.47 M5.99 M4.13 M3.58 M4.72 M Total equity 14.48 M13.88 M15.24 M13.19 M27.56 M Total liabilities & shareholders' equities 20.94 M19.87 M19.37 M16.77 M32.28 M Total debt ————— Net debt —————

Notícias

H.C. Wainwright reitera classificação de compra para IN8bio após captação de recursos

H.C. Wainwright reiterates IN8bio stock rating on financing strength

IN8bio nomeia Kate Rochlin como presidente enquanto mantém cargo de COO

IN8bio appoints Kate Rochlin as president while retaining COO role

IN8bio promotes Kate Rochlin to president and chief operating officer

IN8bio secures up to $40.2 million in private placement for cancer therapy

Mizuho reduz preço-alvo das ações da IN8bio devido a preocupações com financiamento

Mizuho lowers IN8bio stock price target on financing concerns

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

INB-200 shows promise in glioblastoma trial

IN8bio reports promising lupus treatment data